RAMON
CISTERNA CANCER
Investigador/a en el periodo 1981-2017
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Ramón y Cajal (19)
2017
-
Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436
2016
-
Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial
International Journal of Antimicrobial Agents, Vol. 48, Núm. 3, pp. 310-316
-
Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8
2014
-
Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study
Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919
2013
-
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 164-167
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2011
-
Antimicrobial susceptibility of gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum β-lactamases in the smart study in spain (2002-2010)
Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 223-232
2009
-
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations
Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
-
Update on bacterial pathogens: virulence and resistance
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 3-21
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2006
-
Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: Resultados del estudio SMART 2003
Revista Espanola de Quimioterapia, Vol. 19, Núm. 1, pp. 51-59
2005
-
Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter study
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 4, pp. 1604-1607
2002
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
2000
-
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics
Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564
1999
-
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359
1998
-
Situación epidemiológica actual y resistencia de los patógenos respiratorios en Espan̄a
Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 44-51
1997
-
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: A Spanish multicenter study
Journal of Chemotherapy, Vol. 9, Núm. 6, pp. 394-402
1991
-
Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection
Sin título en SCOPUS, Vol. 338, Núm. 8758, pp. 6-9